Back to top

Image: Shutterstock

Waters (WAT) BioAccord System to Expand Portfolio Offerings

Read MoreHide Full Article

Waters Corporation (WAT - Free Report) launched an integrated high-resolution liquid chromatography mass spectrometry (LC-MS) system, namely the Waters BioAccord System with ACQUITY Premier.

The BioAccord System improves analyte recovery and assay-to-assay reproducibility for seamless monitoring of attributes of biotherapeutics as well as helps scientists to get faster information about the samples.

It features the MaxPeak High Performance Surface technology that provides many benefits like increasing the level of detector sensitivity, improved peak shapes, greater peak capacity and reproducibility as well as reducing the requirement of system passivation.

It also features a SmartMS-enabled ACQUITY RDa mass detector that offers guided workflows for seamless deployment.

The recent product is expected to expand the company’s reach to scientists and analysts. This might also contribute to top-line growth in the upcoming period.

LC-MS Market Prospects

With the recent move, Waters has positioned itself well to expand its presence in the growing LC-MS market.

This booming market is backed by increasing research and development expenditure in the healthcare sector as well as the rising number of clinical trials.

Major pharmaceutical and biotechnology companies are expanding their product offerings. This also acts as a key driver for market growth.

According to a report by 360 Market Updates, the global LC-MS market is expected to hit $3.39 billion by 2026, witnessing a CAGR of 6.9% between 2021 and 2026.

Additionally, a report by Industry Research indicates that the market is likely to hit $2.93 billion by 2027, registering a CAGR of 4.9% from 2021 to 2027.

Expanding Product portfolio

The latest move bodes well for Waters’ strong efforts to expand the product portfolio consisting of chromatography consumables and columns, mass spectrometry systems, laboratory automation, integrated solutions, and others.

Apart from the recent launch, it unveiled the TRIOS AutoPilot software that automates thermal analysis workflows, reduces errors, maintains product quality and enhances the productivity of operations.

It also introduced the liquid chromatography system named Waters Arc Premier System that is optimized for chromatographic separations on 2.5-3.5 micron columns.

In addition, it unveiled a high-resolution mass spectrometer named SELECT SERIES Multi Reflecting Time-of-Flight technology with desorption electrospray ionization and matrix-assisted laser desorption ionization imaging sources for applications in pharmaceutical, biomedical, natural products, and materials research.

Further, it introduced Otto SPEcialist Positive Pressure Manifold, which provides more reliability and reproducibility of solid phase extraction with greater efficiency,ideal for various pharmaceutical, biopharmaceutical, food and beverage as well as environmental applications.

We believe that these endeavors will continue to benefit Waters in gaining strong momentum in various end-markets served.

Zacks Rank & Other Stocks to Consider

Currently, Waters carries a Zacks Rank #2 (Buy).

Other similar-ranked stocks in the broader technology sector include Advanced Micro Devices (AMD - Free Report) , Dropbox (DBX - Free Report) and ASML Holding (ASML - Free Report) . You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Long-term earnings growth rates for Advanced Micro Devices, Dropbox, and ASML Holding are currently projected at 44.6%, 40.9%, and 33.5% respectively.